Director – Documentation, Knowledge Management and Automation
Amgen
Director – Documentation, Knowledge Management and Automation
Amgen
Makes biotech medicines for serious illnesses
The Director, Documentation, Knowledge Management and Automation is a key leader within the Amgen India Capability Center (AIN), accountable for establishing, scaling, integrating, and sustaining global documentation, content creation, knowledge management, and automation capabilities that support Amgen’s manufacturing network.
This role defines the vision, operating model, and multi-year roadmap for Documentation, Knowledge Management and Automation, translating Manufacturing Technology and Workforce Strategy (TWFS) objectives into scalable capabilities that improve documentation creation, quality, speed, consistency, compliance, knowledge transfer, automation, and operational effectiveness across the enterprise.
The Director serves as the primary integration point between AIN-based teams and Manufacturing stakeholders, ensuring capabilities are fully embedded into enterprise standards, governance processes, and ways of working. The role has enterprise-wide impact through accountability for service delivery, operational performance, adoption, inspection readiness, capability maturity, and value realization across documentation, knowledge management, content development, automation, and operational support capabilities.
Roles and Responsibilities
Strategy & Roadmap
Execution & Delivery
Governance & Compliance
Stakeholder Engagement
Team Leadership & Capability Building
Preferred Qualifications & Desirable Attributes
Relevant certifications in Quality, Operational Excellence, Lean, Six Sigma, Knowledge Management, Technical Writing, Learning Technologies, or related disciplines.
.Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen